Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04278963Phase 2/3Suspended
Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19
Chinese MedicineCoVID-19
Principalinvestigator
NCT04310865Phase 2/3Suspended
Yinhu Qingwen Granula for the Treatment of Severe CoVID-19
Chinese MedicineCOVID-19Severe Pneumonia
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Yangtze University Health Science Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xiao-Dong Li, M.D.

Hubei Hospital of Traditional Chinese Medicine

Moderately Similar
2 trials

Shared therapeutic areas:

Chinese MedicineCOVID-19Severe Pneumonia

Worked with same sponsors:

China Academy of Chinese Medical SciencesJizhong Energy Fengfeng Group Hospital+5 more
Collaborated on 2 trials
Similarity Score38%

Dong Shang, M.D.

Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Chinese MedicineCOVID-19Severe Pneumonia

Worked with same sponsors:

Jizhong Energy Fengfeng Group HospitalNorth China University of Science and Technology+4 more
Collaborated on 1 trial
Similarity Score34%

Zhong Wang, M.D.

China Academy of Chinese Medical Sciences

Moderately Similar
2 trials

Shared therapeutic areas:

Chinese MedicineCOVID-19Severe Pneumonia

Worked with same sponsors:

Jizhong Energy Fengfeng Group HospitalNorth China University of Science and Technology+4 more
Collaborated on 1 trial
Similarity Score34%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Athena Philis-Tsimikas, MD

Scripps Whittier Diabetes Institute

Related
12 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Wenhong Zhang, MD

Huashan Hospital

Related
4 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Shai a Efrati, MD

Asaf-Harofhe MC

Related
13 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04278963Phase 2/3PrincipalInvestigator

Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19

Chinese MedicineCoVID-19
Suspended
NCT04310865Phase 2/3PrincipalInvestigator

Yinhu Qingwen Granula for the Treatment of Severe CoVID-19

Chinese MedicineCOVID-19Severe Pneumonia
Suspended

All 2 trials loaded